The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

thiothixene     N,N-dimethyl-9-[3-(4- methylpiperazin-1...

Synonyms: SureCN782605, KBioSS_001548, NINDS_000335, SPBio_001485, Oprea1_774264, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Navane

 

Psychiatry related information on Navane

 

High impact information on Navane

  • Forty-one male schizophrenic subjects, 21 with tardive dyskinesia and 20 without, were given a fixed dosage of thiothixene hydrochloride (10 mg orally four times daily) after a drug-free period of one week [2].
  • A random sample of 52 borderline and schizotypal patients was treated with two major neuroleptics, thiothixene and haloperidol, in a double-blind study [11].
  • Thirty-six hospitalized patients with schizophrenia or schizo-affective disorder who were judged unresponsive to conventional treatment were tested 5 days after last receiving medication and retested 4 weeks after treatment with thiothixene, loxapine, or molindone [12].
  • Clozapine increased and thiothixene decreased metabolic rates in the basal ganglia; these effects were most marked on the right side [13].
  • Patients had a second PET scan after an injection of thiothixene to evaluate the effects of acute neuroleptics on glucose metabolism [14].
 

Chemical compound and disease context of Navane

 

Biological context of Navane

 

Anatomical context of Navane

 

Associations of Navane with other chemical compounds

 

Gene context of Navane

  • DISCUSSION: It is likely that the CYP2D6 isoenzyme is not responsible for a high proportion of thiothixene clearance, but one cannot exclude the possibility that a longer paroxetine pretreatment might have caused some inhibition of thiothixene clearance [20].
  • Effect of melperone, two of its metabolites and thiothixene on central monoamine metabolism and prolactin levels in rodents [27].
 

Analytical, diagnostic and therapeutic context of Navane

References

  1. Leukopenia following treatment with thiothixene and haloperidol. Cutler, N.R., Heiser, J.F. JAMA (1979) [Pubmed]
  2. Tardive dyskinesia and steady-state serum levels of thiothixene. Yesavage, J.A., Tanke, E.D., Sheikh, J.I. Arch. Gen. Psychiatry (1987) [Pubmed]
  3. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine. Crowley, T.J., Hydinger-Macdonald, M. Arch. Gen. Psychiatry (1981) [Pubmed]
  4. Fever, tachycardia, and hypertension with acute catatonic schizophrenia. McAllister, R.G. Arch. Intern. Med. (1978) [Pubmed]
  5. Exaggerated hyperprolactinemia in response to thiothixene. Ash, P.R., Bouma, D. Arch. Neurol. (1981) [Pubmed]
  6. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Goldberg, S.C., Schulz, S.C., Schulz, P.M., Resnick, R.J., Hamer, R.M., Friedel, R.O. Arch. Gen. Psychiatry (1986) [Pubmed]
  7. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia. Abuzzahab, F.S., Zimmerman, R.L. The Journal of clinical psychiatry. (1982) [Pubmed]
  8. Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients. Ahmad, S.H., Hasan, K.Z. JPMA. The Journal of the Pakistan Medical Association. (1977) [Pubmed]
  9. Prediction of change in borderline personality disorder. Goldberg, S.C. Psychopharmacology bulletin. (1989) [Pubmed]
  10. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery. Ruiz-Navarro, J.F., Vergara, L., Deutsch, M. Psychopharmacology bulletin. (1976) [Pubmed]
  11. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Serban, G., Siegel, S. The American journal of psychiatry. (1984) [Pubmed]
  12. Cortical laterality and asymmetry of the Hoffmann reflex in psychiatric patients. Goode, D.J., Manning, A.A., Middleton, J.F. Biol. Psychiatry (1981) [Pubmed]
  13. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Buchsbaum, M.S., Potkin, S.G., Marshall, J.F., Lottenberg, S., Teng, C., Heh, C.W., Tafalla, R., Reynolds, C., Abel, L., Plon, L. Neuropsychopharmacology (1992) [Pubmed]
  14. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. Volkow, N.D., Brodie, J.D., Wolf, A.P., Angrist, B., Russell, J., Cancro, R. J. Neurol. Neurosurg. Psychiatr. (1986) [Pubmed]
  15. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report. Balon, R., Berchou, R., Zethelius, M. Canadian journal of psychiatry. Revue canadienne de psychiatrie. (1987) [Pubmed]
  16. Progressive supranuclear palsy with agitation: response to trazodone but not to thiothixine or carbamazepine. Schneider, L.S., Gleason, R.P., Chui, H.C. Journal of geriatric psychiatry and neurology. (1989) [Pubmed]
  17. Perphenazine-induced priapism. Chan, J., Alldredge, B.K., Baskin, L.S. DICP : the annals of pharmacotherapy. (1990) [Pubmed]
  18. Penfluridol and thiothixene. Dosage, plasma levels and changes in psychopathology. Jacobsson, L., von Knorring, L., Mattsson, B., Mjörndal, T., Oreland, L., Perris, C., Rapp, W., Edenius, B., Kettner, B., Magnusson, K.E., Villemoes, P. International pharmacopsychiatry. (1976) [Pubmed]
  19. Plasma levels and clinical effects of thioridazine and thiothixene. Bergling, R., Mjorndal, T., Oreland, L., Rapp, W., Wold, S. Journal of clinical pharmacology. (1975) [Pubmed]
  20. The effect of paroxetine on thiothixene pharmacokinetics. Guthrie, S.K., Hariharan, M., Kumar, A.A., Bader, G., Tandon, R. Journal of clinical pharmacy and therapeutics. (1997) [Pubmed]
  21. Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise. Carlsson, C., Dencker, S.J., Grimby, G., Häggendal, J., Johnsson, G. International journal of clinical pharmacology and biopharmacy. (1976) [Pubmed]
  22. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene. Bjerkenstedt, L., Gullberg, B., Härnryd, C., Sedvall, G. Archiv für Psychiatrie und Nervenkrankheiten. (1977) [Pubmed]
  23. Improved high-performance liquid chromatographic method for the determination of tiotixene in human serum. Dilger, C., Salama, Z., Jaeger, H. Arzneimittel-Forschung. (1988) [Pubmed]
  24. A case report of venlafaxine toxicity. Fantaskey, A., Burkhart, K.K. J. Toxicol. Clin. Toxicol. (1995) [Pubmed]
  25. Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. Azuine, M.A., Tokuda, H., Takayasu, J., Enjyo, F., Mukainaka, T., Konoshima, T., Nishino, H., Kapadia, G.J. Pharmacol. Res. (2004) [Pubmed]
  26. Clinical experience with fluotracen HCL: report of a case. Kulik, F.A., Wilbur, R., Kruckeberg, M. Progress in neuro-psychopharmacology. (1979) [Pubmed]
  27. Effect of melperone, two of its metabolites and thiothixene on central monoamine metabolism and prolactin levels in rodents. Wiesel, F.A., Bjerkenstedt, L., Skett, P. Acta pharmacologica et toxicologica. (1978) [Pubmed]
  28. Analgesic and tranquilizing activity of 5,8-disubstituted 1-tetralone Mannich bases. Welch, W.M., Harbert, C.A., Sarges, R., Stratten, W.P., Weissman, A. J. Med. Chem. (1977) [Pubmed]
  29. Thiothixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables. Ereshefsky, L., Saklad, S.R., Watanabe, M.D., Davis, C.M., Jann, M.W. Journal of clinical psychopharmacology. (1991) [Pubmed]
  30. Plasma levels of thiothixene by radioreceptor assay: clinical usefulness. Van Putten, T., May, P.R., Marder, S.R., Wilkins, J.N., Rosenberg, B.J. Psychopharmacology (Berl.) (1983) [Pubmed]
  31. Quantitation of thiothixene in plasma by high-performance thin-layer chromatography and fluorometric detection. Davis, C.M., Harrington, C.A. Therapeutic drug monitoring. (1988) [Pubmed]
 
WikiGenes - Universities